UnitedHealth Group and Amedisys have pushed back the closure date for their $3.3 billion merger as they fend off a federal challenge to the deal. Home health company Amedisys wrote in a filing ...

https://www.tipranks.com/news/the-fly/insulet-price-target-raised-to-300-from-270-at-btig In a regulatory filing, Amedisys (AMED) stated, “As previously disclosed ...

On Monday, shares of Amedisys (NASDAQ:AMED), a healthcare company with a market capitalization of $2.95 billion, remained steady following the announcement of an extension to its merger agreement ...

UnitedHealth Group's Inc.'s multibillion-dollar acquisition of Amedisys Inc. might not be completed until 2025 after the two companies agreed to waive a deadline for the deal. While legally ...

In a report released today, Ryan Langston from TD Cowen maintained a Hold rating on Amedisys (AMED – Research Report), with a price target of $101.00. The company’s shares opened today at $89.50.

UnitedHealth and home health provider Amedisys have agreed to push back the closure date of their $3.3 billion merger, according to a securities filing last month. The delay comes after the ...

UnitedHealth and Amedisys have agreed to extend the deadline to close their $3.3 billion merger agreement to next year, a filing showed on Friday, as the deal faces close scrutiny from the DOJ.

In a regulatory filing, Amedisys (AMED) stated, “As previously disclosed, on June 26, 2023, Amedisys, UnitedHealth Group (UNH), and Aurora Holdings Merger Sub Inc., a Delaware corporation and ...

Amedisys and UnitedHealth extend merger deadline to December 2025, amid regulatory scrutiny over competition concerns. The waiver includes financial adjustments, such as a $275M break fee and ...

UnitedHealth Group's Inc.'s (NYSE: UNH) $3.3 billion acquisition of Amedisys Inc. (Nasdaq: AMED), announced in mid-2023, might not be completed until 2025 after the two companies agreed to waive a ...